This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bruening, W. Articles by Godwin, A. K. Search for Related Content PubMed PubMed Citation Articles by Bruening, W. Articles by Godwin, A. K.

Expression of OVCA1, a Candidate Tumor Suppressor, Is Reduced in Tumors and Inhibits Growth of Ovarian Cancer Cells¹

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [W. B., A. H. P., D. C. S., A. K. G.]; Wistar Institute, Philadelphia, Pennsylvania 18014 [D. C. S.]; and Department of Microbiology and Immunology, Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 [M. H-M., A. W.]

Loss of all or part of one copy of chromosome 17p is very common in ovarian and breast tumors. OVCA1 is a candidate tumor suppressor gene mapping to a highly conserved region on chromosome 17p13.3 that shows frequent loss of heterozygosity in breast and ovarian carcinomas. Western blot analysis of extracts prepared from breast and ovarian carcinomas revealed reduced expression of OVCA1 compared with extracts from normal epithelial cells from these tissues. Subcellular localization studies indicate that OVCA1 is localized to punctate bodies scattered throughout the cell but is primarily clustered around the nucleus. Attempts to create cell lines that stably expressed OVCA1 from the cytomegalovirus promoter were generally unsuccessful in a variety of different cell lines. This reduction of colony formation was quantified in the ovarian cancer cell line A2780, where it was demonstrated that cells transfected with plasmids expressing OVCA1 had a 50–60% reduction in colony number as compared with appropriate controls, and only a few of these clones expressed OVCA1, albeit at low levels. The clones that expressed exogenous OVCA1 were found to have dramatically reduced rates of proliferation. Reduced growth rates correlated with an increased proportion of the cells in the G₁ fraction of the cell cycle compared with the parental cell line and decreased levels of cyclin D1. The low levels of cyclin D1 appeared to be caused by an accelerated rate of cyclin D1 degradation. Overexpression of cyclin D1 was able to override OVCA1’s suppression of clonal outgrowth. These results suggest that slight alterations in the level of OVCA1, such as would occur after reduction of chromosome 17p13.13 to hemizygosity, may result in cell cycle deregulation and promote tumorigenesis.

This article has been cited by other articles:

				F. He, B. J. Fenner, A. K. Godwin, and J. Kwang White Spot Syndrome Virus Open Reading Frame 222 Encodes a Viral E3 Ligase and Mediates Degradation of a Host Tumor Suppressor via Ubiquitination. J. Virol., April 1, 2006; 80(8): 3884 - 3892. [Abstract] [Full Text] [PDF]

				Y. Nobukuni, K. Kohno, and K. Miyagawa Gene Trap Mutagenesis-based Forward Genetic Approach Reveals That the Tumor Suppressor OVCA1 Is a Component of the Biosynthetic Pathway of Diphthamide on Elongation Factor 2 J. Biol. Chem., March 18, 2005; 280(11): 10572 - 10577. [Abstract] [Full Text] [PDF]

				C. Klebig, S. Seitz, W. Arnold, N. Deutschmann, M. Pacyna-Gengelbach, S. Scherneck, and I. Petersen Characterization of {gamma}-Aminobutyric Acid Type A Receptor-Associated Protein, a Novel Tumor Suppressor, Showing Reduced Expression in Breast Cancer Cancer Res., January 15, 2005; 65(2): 394 - 400. [Abstract] [Full Text] [PDF]

				S. Liu, G. T. Milne, J. G. Kuremsky, G. R. Fink, and S. H. Leppla Identification of the Proteins Required for Biosynthesis of Diphthamide, the Target of Bacterial ADP-Ribosylating Toxins on Translation Elongation Factor 2 Mol. Cell. Biol., November 1, 2004; 24(21): 9487 - 9497. [Abstract] [Full Text] [PDF]

				T. A. Gorr, T. Tomita, P. Wappner, and H. F. Bunn Regulation of Drosophila Hypoxia-inducible Factor (HIF) Activity in SL2 Cells: IDENTIFICATION OF A HYPOXIA-INDUCED VARIANT ISOFORM OF THE HIF{alpha} HOMOLOG GENE similar J. Biol. Chem., August 20, 2004; 279(34): 36048 - 36058. [Abstract] [Full Text] [PDF]

				M. R. Jensen and K. Helin OVCA1: emerging as a bona fide tumor suppressor Genes & Dev., February 1, 2004; 18(3): 245 - 248. [Full Text] [PDF]

				C.-M. Chen and R. R. Behringer Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis Genes & Dev., February 1, 2004; 18(3): 320 - 332. [Abstract] [Full Text] [PDF]

				K. Farrand, B. Delahunt, X.-l. Wang, B. McIver, I. D. Hay, J. R. Goellner, N. L. Eberhardt, and S. K. G. Grebe High Resolution Loss of Heterozygosity Mapping of 17p13 in Thyroid Cancer: Hurthle Cell Carcinomas Exhibit a Small 411-Kilobase Common Region of Allelic Imbalance, Probably Containing a Novel Tumor Suppressor Gene J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4715 - 4721. [Abstract] [Full Text] [PDF]

				C. D. Hough, C. A. Sherman-Baust, E. S. Pizer, F. J. Montz, D. D. Im, N. B. Rosenshein, K. R. Cho, G. J. Riggins, and P. J. Morin Large-Scale Serial Analysis of Gene Expression Reveals Genes Differentially Expressed in Ovarian Cancer Cancer Res., November 1, 2000; 60(22): 6281 - 6287. [Abstract] [Full Text]

				C. Guerardel, S. Deltour, S. Pinte, D. Monte, A. Begue, A. K. Godwin, and D. Leprince Identification in the Human Candidate Tumor Suppressor Gene HIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53 J. Biol. Chem., January 26, 2001; 276(5): 3078 - 3089. [Abstract] [Full Text] [PDF]